Dr. Alessandra Maleddu discusses desmoid tumor, improving patient diagnosis and seeing a sarcoma specialist Researchers identified several socioeconomic and logistic barriers that limit diversity in clinical trials. Black patients had lower rates of utilization and longer wait times for immunotherapy. "... Though many newer therapies specifically target cancer cells, they can still interfere with heart function." This research promotes progress in understanding how tumor genetics differs across individuals of different ancestry. African American and Asian women had significantly lower odds of undergoing breast reconstruction. A drug used to treat some types of leukemia may offer patients with refractory multiple myeloma a new avenue for treatment. This risk poses serious challenges in urban environments. Residents may have limited access to fresh produce Neighborhood environment (eg, exposure to stressors, distance to treatment facilities) may contribute to poor survival. Dr. Terra Wonsettler discusses the cardiotoxicity among cancer drugs and cancer patient awareness of these risks. What goes on at a Hospice Meeting? Shocked 20-year-old diagnosed with CRC Restrictive trial eligibility criteria and geographic limitations likely contribute to these disparities. Dr. Barry and colleagues found that living in a disadvantaged neighborhood was associated with a significantly higher More early-stage lung cancers were diagnosed in individuals with a history of smoking who were adherent to annual screening. Dr. Hertler breaks down the FDA’s restricting PD-1 inhibitor drugs for PD-L1-negative stomach and esophageal cancers Only 61% of eligible Black adults reported being current with screening as of 2021—well below the national goal of 80%. Researchers selected representative groups for individuals with more than a 5% risk of developing BE or EC Most Americans don’t know that what they eat and drink and how much they move impact their risk of colorectal cancer. Researchers categorize White and Black patients with colon cancer based on disease stage and propensity-score match. Dr. Terra Wonsettler talks about cardiotoxicity prevalence of cancer drugs among patients and accelerated drug approval.